Explore All 191 Merger Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | June 5, 2019 |
| Target | Athlone Laboratories |
| Sector | Life Science |
| Buyer(s) | Kent Pharma |
| Deal Type | Merger |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1986 |
| Sector | Life Science |
| Revenue | 90M EUR (2012) |
Kent Pharma is engaged in the development, manufacture, sales, marketing, and distribution of generic pharmaceutical products for the British, Irish, and international markets. The company’s portfolio includes licensed products, with a focus on beta-lactam antibiotics such as penicillin V, flucloxacillin, and amoxicillin, which are used in the treatment of bacterial infections including throat, ear, and respiratory tract infections. Kent Pharma was founded in 1986 and is based in Ashford, United Kingdom.
| Deal Context for Buyer | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science | 1 of 1 |
| Type: Merger | 1 of 1 |
| Country: Ireland | 1 of 1 |
| Year: 2019 | 1 of 1 |
